BMJ 1995;311:451 (12 August)

Letters

General practitioners would expect to see aplasia roughly once each century

EDITOR,--Although chloramphenicol eye drops may induce bone marrow aplasia, it might be helpful to put the risk in perspective.1 In our practice of 4600 patients we use chloramphenicol eye drops as our first line treatment for conjunctivitis and after removal of foreign bodies. We also frequently prescribe chloramphenicol drops on the advice of local ophthalmologists. In total, we issue 360 prescriptions for chloramphenicol drops or ointment a year. Assuming that the risk of aplastic anaemia after topical administration is the same as that after oral administration, we would expect to see one case every 83-138 years in the practice as a whole, or one case every 240-400 years per general practitioner.

General practitioner General practitioner Caldbeck Surgery, Caldbeck, Wigton, Cumbria CA7 8DS

Jim Cox, Eleri M Roderick 


  1. Doona M, Walsh JB. Use of chloramphenicol as topical eye medication: time to cry halt? BMJ 1995;310:1217-8. (13 May.)

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Use of chloramphenicol as topical eye medication: time to cry halt?
Marie Doona and J Bernard Walsh
BMJ 1995 310: 1217-1218. [Extract] [Full Text]




Access jobs at BMJ Careers
Whats new online at Student 

BMJ